Vaccines, which help the body recognize infectious microorganisms and stage a stronger and faster response, are made up of proteins that are specific to each type of microorganism. In the case of a virus, viral proteins—or ...
Oct 1, 2020
0
1
An in-depth Garvan study of how the immune system generates effective antibodies provides new insights for vaccine design.
Aug 24, 2020
0
112
A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion that goes by the acronym LION, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization. These antibodies ...
Jul 20, 2020
0
14
From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the ...
Jul 15, 2020
0
11
Strains of a common subtype of influenza virus, H3N2, have almost universally acquired a mutation that effectively blocks antibodies from binding to a key viral protein, according to a study from researchers at Johns Hopkins ...
Jul 10, 2020
1
212
A recent study by Monash University has looked at the role plasma cells and their longevity play in the effectiveness of vaccines in the body and suggests that components within vaccine design are the key.
Jun 29, 2020
0
0
The COVID-19 virus is constantly changing as it moves from person to person. To fight the virus today and prepare for what it may look like tomorrow, researchers need to be able to track its development.
Jun 15, 2020
0
2
The goal of a vaccine is to trigger a response that safely protects against an infection and/or the burden of disease. While this is true for all vaccines, the steps leading to a safe and effective product can be different ...
May 12, 2020
0
143
Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel vaccine consisting of DNA and recombinant proteins?proteins composed of a portion of an HIV protein and another unrelated protein. This vaccine ...
Jul 23, 2019
0
149
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus has been designed in an international research effort. RSV is second only to malaria as a cause of infant mortality worldwide. The new vaccine ...
Mar 7, 2019
0
80
